Vaccine Stocks Pop As Scientists Grapple With A Terrifying New Covid Variant - Investor's Business Daily

1. Vaccine Stocks Pop As Scientists Grapple With A Terrifying New Covid Variant  Investor's Business Daily
2. Omicron COVID-19 variant: Pfizer, BioNTech say vaccine could be reworked in 100 days to counter strain  Fox Business
3. Merck says its Covid antiviral treatment less effective than first thought  Financial Times
4. With the Virus Still in Charge, Pfizer Can Be Flexible: Here's My Plan  RealMoney
5. Vaccine makers move quickly against new omicron Covid variant, testing already under way  CNBC
6. View Full Coverage on Google News

from Top stories - Google News https://ift.tt/3D1aLsm
via gqrds